TPST - Tempest falls after new trial data for liver cancer therapy
2024-06-20 10:52:39 ET
More on Tempest Therapeutics
- Tempest Therapeutics: Multiple 2024 Catalysts Make This A Must Watch
- Tempest Therapeutics reports Q1 results
- Seeking Alpha’s Quant Rating on Tempest Therapeutics
- Historical earnings data for Tempest Therapeutics
- Financial information for Tempest Therapeutics